ADAM10 and Dimebolin

2009

Understanding the hypothesized relationship between ADAM10, a newly identified Alzheimer’s-related gene, and dimebolin, the key ingredient in the anti-Alzheimer’s drug Dimebon.


Funding to Date

$150,000

Focus

Drug Discovery

Researchers

Sam Gandy, M.D., Ph.D.